Tag Archives: OREX

Top 5 Low Price Stocks To Own Right Now

Peyto (OTCPK:PEYUF) is a Canadian E&P company whose production profile is dominated by dry gas (92%). With the low price of natural gas, it has been a tough couple of years for Peyto’s shareholders. That said, the company has maintained its dividend payout through the commodity price downturn. Recently natural gas prices have recovered from their lows, but Peyto’s stock has not kept pace. In fact, it’s gone the other direction:

Click to enlarge

As the chart above show, the stock is down ~13% over the past three months as natural gas – as measure by both the Henry Hub and AECO indexes – has rallied sharply with significant winter withdrawals and forecasts that additional cold weather is on the way:

Top 5 Low Price Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Both of these stocks are overlooked, undervalued, and cash flow machines. The companies are Ascent Capital Group (ASCMA) and Covanta Holdings (CVA).

  • [By Lisa Levin]

    Tuesday afternoon, the industrial sector proved to be a source of strength for the market. Leading the sector was strength from NL Industries Inc (NYSE: NL) and Ascent Capital Group Inc (NASDAQ: ASCMA).

Top 5 Low Price Stocks To Own Right Now: Roper Technologies, Inc.(ROP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Aside from Outperform-rated Roper Technologies (ROP) SaaS platforms, which account for over +50% of earnings today, GEs Digital business strategy is the most ambitious ramp within the industrials sector. GE has made a bold bet on its game-changing Predix operating system for the Industrial IoT, which was launched in Feb-2016

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Monica Gerson]

    Analysts are expecting Roper Technologies Inc (NYSE: ROP) to have earned $1.46 per share on revenue of $895.87 million in the latest quarter. Roper Technologies shares declined 0.05 percent to close at $178.63 on Friday.

  • [By Monica Gerson]

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

    Express Scripts Holding Company (NASDAQ: ESRX) is expected to post its quarterly earnings at $1.22 per share on revenue of $25.20 billion.

Top 5 Low Price Stocks To Own Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top 5 Low Price Stocks To Own Right Now: FORM Holdings (FH)

Advisors’ Opinion:

  • [By Matthew Briar]

    Looking for a quick, money-making trading idea? Put FORM Holdings Corp. (NASDAQ:FH) on your watchlist, if not yet in your portfolio. FH shares are knocking on the door of a breakout move, and one more nudge could do the trick.

    There are a couple of factors in play here. One of the is the converging wedge pattern that’s developed after the October-December finally stabilized. The upper boundary of that wedge at $2.40 has been tested several times since late last year, but FORM Holdings could never get past the hurdle. At the same time, several key moving average lines seem to be acting as support — even if unevenly — keeping FH positioned well for a breakout effort.

Top 5 Low Price Stocks To Own Right Now: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

penny stock quotes

In September 2016, privately held tech ‘unicorn’ Apttus (Private:APTUS) raised $88 million in late stage venture capital investment and its CEO has indicated a desire to IPO in 2017.

A ‘unicorn’ is a tech startup that has been valued at or more than $1 billion by private investors.

Founded in 2006 by CEO Kirk Krappe, Apttus has developed a suite of enterprise contract management solutions to streamline the sales and quoting process.

Here’s a brief overview of the company’s approach:

(Source: Apttus)

San Mateo, California-based Apttus, which is backed by investors such as K1 Investment Management, Salesforce (NYSE:CRM), Kuwait Investment Authority, Gulf Islamic Investments, Kia Motors and ICONIQ Capital, has a raised at least $274 million in private investment.

I recently spoke with Chief Revenue Officer Kamal Ahluwalia about the company’s history and future potential.

(The following has been edited for brevity.)

DJ: Apttus operates in the contract management space which is pretty large and dynamic – how would you describe the major technology trends currently impacting the space?

penny stock quotes: Dean Foods Company(DF)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap Dean Foods Co (NYSE: DF) is scheduledfor before the market opens onThursday (February 16th) with the strongest volume performance seen in yearsbeing reported the last time around.

  • [By Jon C. Ogg]

    Dean Foods Co. (NYSE: DF) was raised to Overweight from Neutral with a $22 price target (versus an $18.75 close) at JPMorgan. Dean Foods has a 52-week range of $15.69 to $22.31 and a consensus analyst price target of $20.17.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Peter Graham]

    A long term performance chart shows shares of WhiteWave Foods peakingtwo summers in a rowwhile mid capThe Hain Celestial Group, Inc (NASDAQ: HAIN) also peaked two summers in a rowandsmall cap Dean Foods Co (NYSE: DF) has been moving a bit higher for the past couple of years:

  • [By Lisa Levin]

    Tuesday afternoon, the non-cyclical consumer goods & services shares climbed by 0.71 percent. Meanwhile, top gainers in the sector included Weight Watchers International, Inc. (NYSE: WTW), up 17 percent, and Dean Foods Co (NYSE: DF), up 6 percent.

  • [By Lisa Levin]

    Dean Foods Co (NYSE: DF) posted weaker-than-expected earnings for its first quarter on Tuesday.

    Dean Foods said it earned $0.13 per share in the first quarter on revenue of $2.00 billion; Analysts were expecting the company to earn $0.18 per share on revenue of $1.097 billion.

penny stock quotes: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Citrix Systems, Inc. (NASDAQ: CTXS) which jumped 6.8% to $84.93. The stocks 52-week range is $59.72 to $87.99. Volume was 5.19 million which is well above the daily average of around 2.09 million shares.

  • [By Ben Levisohn]

    Citrix Systems (CTXS)soared nearly to the top of the S&P 500 today afterreports it had hired Goldman Sachs (GS) to pursue a sale of the company.

    S. MARTIN/AFP/Getty Images

    Citrix Systemsgained 6.8% to $84.93 today, while the S&P 500 finished little changed at 2,373.47.

    Business Insider’s Matt Weinbergerhas the details:

    Citrix, the $13 billion tech company best known for software like GoToMeeting, is working with Goldman Sachs to negotiate a possible sale, reports Bloomberg, citing anonymous sources.

    This isn’t the first time that Citrix has shopped itself around: in late 2015, and under pressure from activist shareholder Elliott Management, Citrix was said to have unsuccessfully tried to find a buyer.

    Citrix Systems market cap rose t0 $13.3 billion today from $12.4 billion on Friday. It reported net income of $536 million on sales of $3.4 billion in 2016.

  • [By Ben Levisohn]

    Wynn Resortsgained 4.8% to $104.30 today, while the S&P 500 finished little changed at2,373.47. At 2:45, Wynn was easily the top performing stock in the S&P 500, only to be surpassed by Citrix’s (CTXS) late day surge.

penny stock quotes: Enphase Energy, Inc.(ENPH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    UPDATE: I stand corrected. There does appear to be a reason for First Solar’s market-leading move today. Axiom Capital’s Gordon Johnson attributes the rise to the $10 million investment in Enphase Energy (ENPH), which makes “microinverter systems for the solar photovoltaic industry,” by investors T.J. Rodgers and John Doerr.

penny stock quotes: ZTE Corporation (ZTCOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Chinese telco equipment giant ZTE (OTCPK:ZTCOF) has been actively cooperating and communicating with relevant U.S. government departments in order to reach a conclusion of the investigation related to the compny’s violations of sanctions on Iran.

  • [By SEEKINGALPHA.COM]

    The United States has a history of preventing Chinese companies that are even suspected of being state-owned from selling certain products into key industries. Huawei and ZTE (OTCPK:ZTCOF), for example, were under harsh scrutiny for their telecommunications equipment.

penny stock quotes: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

penny stock quotes: Extreme Networks Inc.(EXTR)

Advisors’ Opinion:

  • [By Azam Zariff]

    Extreme Networks, Inc. (NASDAQ: EXTR), a communication company, has been on a surge the past year. From the low of $2.32 to high of $8.11 in just over a year, this stock might continue to rise. Besides the strong financials, and positive acquisition news, EXTR current price is testing the high of $8.11 and once the price breaks above $8.11, we can expect the price to surge.

Top Bank Stocks To Own Right Now

In August 2016, BlackBerry Ltd. (NYSE:BB) filed suit against Avaya Inc. (OTCQX:AVYA) for patent infringement. BlackBerry stated that Avaya was infringing on eight BlackBerry held patents in multiple products.

In January 2017, Avaya filed for Chapter 11 bankruptcy protection, putting a halt to the lawsuit. However, the alleged products were still being sold by the company.

In February 2017, BlackBerry requested that the court lift the stay on the patent suit and the shield of Avaya’s bankruptcy has been cracked in April 2017, granting BB’s application.

On December 15th, few days ago, Avaya emerged from Chapter 11 after completing its debt restructuring, and it is now publicly quoted on OTCMKTS with a market cap of around $8B.

What will it imply for BlackBerry’s lawsuit? Apparently not much: it will keep its ordinary court path, which was allowed to continue in April 2017, after a New York bankruptcy court cracked the protection shield of Avaya’s Chapter 11.

Top Bank Stocks To Own Right Now: Old Point Financial Corporation(OPOF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.13 percent. Meanwhile, top losers in the sector included Adams Natural Resources Fund Inc (NYSE: PEO), down 4 percent, and Old Point Financial Corporation (NASDAQ: OPOF) down 3 percent.

Top Bank Stocks To Own Right Now: Halliburton Company(HAL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Halliburton (HAL) : “I liked Halliburton’s analyst day, but I think Schlumberger (SLB) is even better.”

    Noble Energy (NBL) : “Noble’s good. It’s a very well-run, conservative company. It should do well in this environment.”

  • [By Ben Levisohn]

    Halliburton (HAL) has gotten beaten up this year…and even today’s earnings beat doesn’t capable of reversing its fortunes.

    Getty Images

    Halliburton reported a profit of 4 cents, beating forecasts for 3 cents, on sales of $4.28 billion, narrowly edging expectations for $4.27 billion. Halliburton’s shares were trading higher before the market opened, but have declined have declined 0.3% to $46.90 at 1:56 p.m. today.

    Evercore ISI’s James West sees a “margin explosion” coming for Halliburton during the second half of the year, while comparing the oil-services giant to LeBron:

    With the start of the year already regarded as a transition period, we view the companys decision to sacrifice near term margins in order to accelerate long-term profitability and revenue growth as a defensive, yet calculated, and preemptive maneuver. Execution does remain a risk but naysayers seem to utter similar indecencies about LeBron James each year as the playoffs arrive. You dont doubt the king, and HAL is the clear market leader when it comes to NAM completions, in our view. The change in HALs reporting format makes syncing HALs commentary with its financials more difficult, but NAM comprised 68% and 61% of C&P revenues in 2014 and 2015, respectively (71% and 21% of EBIT). As such, the broader segment should be a good proxy for the region. Abatement of cost inflation, or at least a deceleration as we progress beyond the first step-change in activity of the cycle should serve as an additional tailwind for margins. The most likely benefit will come from proppant costs as sand mines resume processing finer mesh grades following the winter hiatus. Additional frac capacity is being reactivated at leading edge prices, evidenced by the fact that incremental margins improved throughout the first quarter, and the company continues to repair legacy contracts and commitments. The improvement of the broader po

  • [By Lisa Levin]

    Halliburton Company (NYSE: HAL) reported better-than-expected earnings for its first quarter on Monday.

    Halliburton posted adjusted earnings of $0.04 per share in the quarter on revenue of $4.28 billion; Analysts were expecting the company to earn $0.03 per share on revenue of $4.26 billion.

  • [By Matthew DiLallo]

    Following a series of M&A announcements in the oilfield-services sector since the onset of the oil market downturn, French oil-field service company Technip and U.S. oilfield equipment company FMC Technologies (NYSE:FTI) hooked up in an all-stock deal valuing the combined company at $13 billion. Shareholders of each company will own 50% of the combined entity, to be named TechnipFMC, which implies a roughly $6.5 billion acquisition valuation for each entity. The transaction, which should close early next year, will “combine Technip’s innovative systems and solutions, state-of-the-art assets, engineering strengths, and project management capabilities with FMC Technologies’ leading technology, manufacturing, and service capabilities.” Further, it should save $400 million in annual costs by 2019. Moreover, it will enable the combined company to compete better against larger oil-field service rivals Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), and Schlumberger (NYSE:SLB), which have all gained strength during the downturn either through M&A activities or cost savings initiatives.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

Top Bank Stocks To Own Right Now: TransUnion(TRU)

Advisors’ Opinion:

  • [By JJ Kinahan]

    Ready To Shop? A highlight this coming week is Black Friday, and recent data hint that shoppers might be ready. A record 195.9 million consumers now have access to revolving credit such as bank-issued and private label credit cards, TransUnion (NYSE: TRU) said in a recent press release. This is the highest level of revolving credit access since TRU began measuring the variable and is greater than the 192.6 million consumers who had access to such credit products in Q3 2016. “The third quarter of 2017 exhibited a lending market that continued to operate in a stable manner, with consumers continuing to gain access to credit and take advantage of that access,” said Ezra Becker, senior vice president and head of research and consulting for TransUnion, in the press release. “However, we are beginning to see a slowdown in originations, which may be a signal of saturation in the lower-risk credit tiers and some pull-back in lender risk appetite in the higher-risk tiers.” Still, Becker predicted a “robust holiday shopping season.”

Top Bank Stocks To Own Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top Bank Stocks To Own Right Now: Piedmont Natural Gas Company Inc.(PNY)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    Duke also recently has expanded on its natural gas efforts, and will add numerous more natural gas customers when its buy-out of Piedmont Natural Gas Company, Inc. (PNY) goes through.

Top 5 Value Stocks To Own For 2018

Executives at Deutsche Bank AG are contemplating dramatic options for the German lender, including selling all or part of a key business, a sign of growing pressure to speed up a flagging overhaul.

This weekend, senior executives are meeting to debate some of these options, according to people familiar with the plans. One has already been floated: a merger with Germany’s second-largest bank by market value, Commerzbank AG, the people said. Deutsche Bank and Commerzbank held preliminary discussions about a tie-up in August, before concluding last week it wasn’t viable.

Chief Executive John Cryan, who was named co-CEO in July 2015, has set out a long-term plan of shrinking Deutsche Bank and cutting costs. But the merger discussions and the weekend summit signify that the bank may not have the luxury of a drawn-out revamp. On Wednesday, Mr. Cryan found himself on stage at a financial conference in Frankfurt batting back speculation about a merger.

Top 5 Value Stocks To Own For 2018: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top 5 Value Stocks To Own For 2018: Navigant Consulting, Inc.(NCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Navigant Consulting, Inc. (NYSE: NCI) were down 14 percent to $17.02 after the company posted downbeat quarterly results.

    Hertz Global Holdings, Inc (NYSE: HTZ) was down, falling around 18 percent to $14.24. Barclays downgraded Hertz from Equal-Weight to Underweight.

Top 5 Value Stocks To Own For 2018: Cal-Maine Foods, Inc.(CALM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Rite Aid Corporation (NYSE: RAD) to report quarterly earnings at $0.04 per share on revenue of $8.23 billion before the opening bell. Rite Aid shares gained 0.83 percent to $8.54 in after-hours trading.
    Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected profit for its first quarter and issued a strong forecast for the current quarter. Micron shares climbed 9.91 percent to $22.62 in the after-hours trading session.
    Analysts expect Cal-Maine Foods Inc (NASDAQ: CALM) to post quarterly earnings at $0.48 per share on revenue of $262.83 million after the closing bell. Cal-Maine shares rose 0.12 percent to $42.75 in after-hours trading.
    Red Hat Inc (NYSE: RHT) reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced that its CFO Frank Calderoni is stepping down. Red Hat shares tumbled 10.15 percent to $71.69 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Tyler Crowe, Jordan Wathen, and Beth McKenna]

    So we asked three of our contributors to highlight a stock they see as a real underdog in the market today and why investors should be watching this stock. Here’s a quick look into why they picked banker Wells Fargo (NYSE:WFC), railcar manufacturer Greenbrier Companies (NYSE:GBX) , and egg wholesaler Cal-Maine Foods (NASDAQ:CALM)

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said that Cal-Maine Foods Inc (NASDAQ: CALM) had unusually high options volume on Friday. Traders were buying the May 45 calls and Jon Najarian decided to follow the trade. He is planning to hold the position for 1 to 2 months.

Top 5 Value Stocks To Own For 2018: Marvell Technology Group Ltd.(MRVL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Marvell Technology Group Ltd. (NASDAQ: MRVL) shares shot up 10 percent to $14.70 after the company reported upbeat Q3 results and announced a $1 billion share buyback.

  • [By Chris Lange]

    When Marvell Technology Group Ltd. (NASDAQ: MRVL) released its fiscal third-quarter results after the markets closed on Tuesday, it posted $0.34 in earnings per share (EPS) and $616.3 million in revenue. Consensus estimates had called for $0.33 in EPS on revenue of $613.1 million. The same period of last year reportedly had EPS of $0.21 and $604.75 million in revenue.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday’s regular session.

  • [By Peter Graham]

    Mid cap fabless semiconductor stock Marvell Technology Group Ltd (NASDAQ: MRVL) reported fiscal Q1 2018 earnings after the Thursday market close that beat expectations. Net revenue was $579.180 million versus $519.383 million andnet income was $96.970 million versus a net loss of $13.271 million. The CEO commented:

Top 5 Value Stocks To Own For 2018: Xerium Technologies Inc.(XRM)

Advisors’ Opinion:

  • [By kiplinger]

     52-week high: $18.93 


    52-week low: $11.01 

    Annual revenues: $492.9 million 

    Xerium Technologies (XRM), a manufacturer of products used in papermaking, is a favorite of micro-cap expert Dan Abramowitz, who heads Hillson Financial Management, in Rockville, Md. Abramowitz calls the company “a turnaround story that is now at an inflection point.” Changes that a new management team put into effect in 2012 should start bearing fruit. The stock’s price-earnings ratio is a mere 7, based on the average of analysts’ earnings estimates for 2016.

best stocks and shares to invest in

After surging briefly to an all-time high of $3,000, bitcoin has been undergoing a dazzling reversal of late, with the digital currency on track to post its worst weekly decline in more than two years.

Bitcoin
BTCUSD, +1.73%
has dropped 18.5% over the past week to a value of $2,317, which would mark its steepest weekly decline since Jan. 16, 2015, according to WSJ Market Data Group. Thursdays more-than-15% drop would represent its largest one-day plunge since Jan. 14, 2015.

best stocks and shares to invest in: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).

best stocks and shares to invest in: LeMaitre Vascular, Inc.(LMAT)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares rose by just 0.6 percent. Meanwhile, top losers in the sector included LeMaitre Vascular Inc (NASDAQ: LMAT), down 5 percent, and pSivida Corp. (NASDAQ: PSDV), down 3 percent.

best stocks and shares to invest in: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

best stocks and shares to invest in: American Superconductor Corporation(AMSC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to